180
Views
20
CrossRef citations to date
0
Altmetric
Migraine

Sumatriptan (50 mg tablets vs. 25 mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptive-induced menstrual migraine: a pilot study

, , , , , , , & show all
Pages 773-779 | Received 30 Dec 2009, Accepted 15 Apr 2010, Published online: 08 Jun 2010

References

  • Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343–349.
  • MacGregor A. Who gets migraine and why? In: MacGregor A, editor. Menstrual migraine in women. London, UK: Martin Dunitz Ltd; 1999. pp 59.
  • Loder EW. Menstrual migraine: pathophysiology, diagnosis, and impact. Headache 2006;46 (Suppl 2):S55–S60.
  • MacGregor EA. Menstrual migraine: a clinical review. J Fam Plann Reprod Health Care 2007;33:36–47.
  • Headache Classification Subcommittee of the International Headache Society (IHS). The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004;24(Suppl 1):1–169.
  • MacGregor EA. “Menstrual” migraine: towards a definition. Cephalalgia 1996;16:11–21.
  • MacGregor EA, Frith A, Ellis J, Aspinall L, Hackshaw A. Incidence of migraine relative to menstrual cycle phases of rising and falling estrogen. Neurology 2006;67:2154–2158.
  • Massiou H, MacGregor EA. Evolution and treatment of migraine with oral contraceptives. Cephalalgia 2000;20:170–174.
  • Sulak PJ, Scow RD, Preece C, Riggs M, Kuehl TJ. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 2000;95:261–266.
  • Loder E, Buse DC, Golub JR. Headache as a side effect of combination estrogen-progestin oral contraceptives: a systematic review. Am J Obstet Gynecol 2005;193:636–649.
  • Granella F, Sances G, Allais G, Nappi RE, Tirelli A, Benedetto C, Brundu B, Fachinetti F, Nappi G. Characteristics of menstrual and non-menstrual attacks in women with menstrually related migraine referred to headache centers. Cephalalgia 2004;24:707–716.
  • MacGregor A. Migraine associated with menstruation. Funct Neurol 2000;15(Suppl 3):S143–S153.
  • Solbach MP, Waymer RS. Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan. Obstet Gynecol 1993;82:769–772.
  • Facchinetti F, Bonellie G, Kangasniemi P, Pascual J, Shuaib A. The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine. The Sumatriptan Menstrual Migraine Study Group. Obstet Gynecol 1995;86:911–916.
  • Gross MLP, Barrie M, Bates D, Dowson A, Elrington G. The efficacy of oral sumatriptan in menstrual migraine: a prospective study. Cephalalgia 1995;15(Suppl 14):227.
  • Nett R, Landy S, Shackelford S, Richardson MS, Ames M, Lener M. Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine. Obstet Gynecol 2003;102:835–842.
  • Landy S, Savani N, Shackelford SJ, Loftus J, Jones M. Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine. Int J Clin Pract 2004;58:913–919.
  • Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgia and facial pain. Cephalalgia 1988;8:1–96.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.